Vyhľadávanie // SOLEN

Headache as an adverse drug effect
MUDr. Andrea Raganová, MUDr. Ján Rajec, prof. MUDr. Milan Kriška, DrSc.
(4/2006, Spectrum )
Prophylactic treatment of migraine and the most common mistakes
MUDr. Babeta Hofericová
(4/2022, Interdisciplinary consilium )
Drug induced headache (Medication overuse headache)
doc. MUDr. Peter Špalek, PhD.
(7-8/2009, Interdisciplinary consilium )
Biologic treatment versus prophylactic treatment of migraine
MUDr. Jana Martinková, PhD.
(3/2021, Interdisciplinary consilium )

CGRP monoclonal antibodies for migraine prophylaxis
MUDr. Tomáš Nežádal, Ph.D.
(5/2019, Review articles )
Botulinum toxin type A for the migraine prophylactic treatment Botulinum toxin type A for the migraine prophylactic treatment
MUDr. Andrea Bártková, Ph.D.
(2/2017, Review articles )
Budoucí možnosti genové terapie bolesti
RNDr. Omar Šerý, Ph.D., Prof. William Didden, MD., Ph.D.
(2/2006, Main topic )
The use of anti-CGRP monoclonal antibodies amongst wide variety of patients
MUDr. Markéta Škodová
(1/2023, Review articles )
Cognitive impairment in chronic migraine
MUDr. Petra Migaľová
(4/2023, Review articles )
Prophylactic treatment of migraine and the most common mistakes
MUDr. Babeta Hofericová
(3/2021, Review articles )
Mediaction overuse headache
MUDr. Jolana Marková
(1/2012, Main topic )
Primární bolesti hlavy – léčba dnes a zítra
MUDr. Jolana Marková , MUDr. Rudolf Kotas, Ph.D.
(3/2018, Review articles )
Deprese u neurologických onemocnění: výskyt a její léčba
MUDr. Sylva Racková
(3/2018, From the boundary of neurology )
Sleep and headache
prof. MUDr. Karel Šonka, DrSc., MUDr. Simona Dostálová, Ph.D.
(6/2012, Review articles )
Application of antiCGRP prophylaxis episodic and chronic migraines in praxis
MUDr. Petra Migaľová
(6/2022, Review articles )
Eptinezumab – the new anti-CGRP monoclonal antibody for prophylactic treatment of migraine
MUDr. Rudolf Kotas, Ph.D.
(6/2022, Review articles )

Search